PPARGC1A was found to be elevated in CTCs from a variety of experimental models [78], and has been shown to play a role in oxidative phosphorylation in breast and pancreatic cancer cells, helping them meet their growing demand for energy as they proliferate rapidly [78,79]. The gene discussed is PPARGC1A; the disease is familial pancreatic carcinoma.